Literature DB >> 1413846

The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.

Y Ito1, Y Fujimoto, T Obara.   

Abstract

Fifty-six patients with pheochromocytoma underwent surgery during the 9-year period from 1981 to 1990. These patients were divided into two groups according to whether the dominant plasma concentration was of epinephrine or norepinephrine. Plasma levels of the catecholamines were stratified into three grades at 5 and 10 times the normal upper limit. Pre-operative disturbances of blood pressure, sustained or paroxysmal, and normal blood pressure were highly correlated with the dominantly secreted catecholamine and its plasma concentration. Thirteen patients with high plasma norepinephrine levels (greater than or equal to 10 times normal) had sustained hypertension while 18 patients with moderate to high plasma epinephrine levels (greater than or equal to 5 times normal) had paroxysmal hypertension. In the majority of normotensive patients (12 of 14), plasma catecholamine levels were less than 10 times the upper normal limit. Urinary excretion of dopamine and size of the tumor were analyzed according to these patient groups. In the norepinephrine dominant group, urinary dopamine excretion tended to be proportional to the plasma epinephrine levels and when the patients were normotensive, urinary dopamine excretion decreased. In norepinephrine-secreting patients, urinary dopamine tended to be inversely correlated with the plasma norepinephrine level; however dopamine did not prevent the hypertensive action of norepinephrine. Tumor size showed no correlation with the plasma levels of catecholamine in the moderate to high plasma catecholamine groups. We conclude that the plasma catecholamine type and its level are the most important factors in determining the patterns of blood pressure disturbances of patients with pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413846     DOI: 10.1007/bf02067379

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma.

Authors:  D S Goldstein; R Stull; G Eisenhofer; J C Sisson; A Weder; S D Averbuch; H R Keiser
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

2.  An asymptomatic catecholamine-secreting pheochromocytoma.

Authors:  I Taubman; O H Pearson; A H Anton
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

Review 3.  The incidentally discovered adrenal mass.

Authors:  P M Copeland
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

4.  Blood pressure regulation in pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; S C Textor; R W Gifford; D G Vidt
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

5.  Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.

Authors:  E L Bravo; R C Tarazi; R W Gifford; B H Stewart
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

6.  Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion.

Authors:  C Proye; P Fossati; P Fontaine; J Lefebvre; M Decoulx; J L Wemeau; D Dewailly; E Rwamasirabo; P Cecat
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

7.  The hemodynamic relevance of free and conjugated dopamine in pheochromocytoma.

Authors:  O Kuchel; N T Buu; M Bourque; P Hamet; P Larochelle
Journal:  J Clin Endocrinol Metab       Date:  1982-06       Impact factor: 5.958

8.  Plasma catecholamine levels in the diagnosis and management of pheochromocytoma.

Authors:  B Hamberger; S Arnér; P Eskilsson; N Lindvall; S Werner; P O Granberg
Journal:  Surg Gynecol Obstet       Date:  1981-03

9.  Pheochromocytoma: current status and changing trends.

Authors:  J A van Heerden; S G Sheps; B Hamberger; P F Sheedy; J G Poston; W H ReMine
Journal:  Surgery       Date:  1982-04       Impact factor: 3.982

10.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

View more
  20 in total

Review 1.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Paroxystic hypertension in a long-term hemodialyzed patient. Successful adrenalectomy for a dopamine-producing pheochromocytoma.

Authors:  A Ferrante; R Bellantone; A Barbarino; S Corsello; C A Rota; R Ranieri; L Sollazzi; M Sciarra; F Meo; G Luciani
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

3.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

4.  Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.

Authors:  Graeme Eisenhofer; Karel Pacak; Thanh-Truc Huynh; Nan Qin; Gennady Bratslavsky; W Marston Linehan; Massimo Mannelli; Peter Friberg; Stefan K Grebe; Henri J Timmers; Stefan R Bornstein; Jacques W M Lenders
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

5.  Norepinephrine deficiency with normal blood pressure control in congenital insensitivity to pain with anhidrosis.

Authors:  Lucy Norcliffe-Kaufmann; Stuart D Katz; Felicia Axelrod; Horacio Kaufmann
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

6.  Dopamine-secreting pheochromocytomas: in search of a syndrome.

Authors:  Luc A Dubois; Daryl K Gray
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

7.  Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.

Authors:  Graeme Eisenhofer; Thanh-Truc Huynh; Abdel Elkahloun; John C Morris; Gennady Bratslavsky; W Marston Linehan; Zhengping Zhuang; Brian M Balgley; Cheng S Lee; Massimo Mannelli; Jacques W M Lenders; Stefan R Bornstein; Karel Pacak
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

8.  Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma.

Authors:  Edwin W Lai; Shiromi M Perera; Bas Havekes; Henri J L M Timmers; Frederieke M Brouwers; Beverly McElroy; Karen T Adams; Shoichiro Ohta; Robert A Wesley; Graeme Eisenhofer; Karel Pacak
Journal:  Endocrine       Date:  2008-11-04       Impact factor: 3.633

9.  Non-invasive estimation of systolic blood pressure and diastolic blood pressure using photoplethysmograph components.

Authors:  Incheol Jeong; Sukhwan Jun; Daeja Um; Joonghwan Oh; Hyungro Yoon
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

Review 10.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.